| Q28539764 | A stable and reproducible human blood-brain barrier model derived from hematopoietic stem cells |
| Q30375556 | A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function. |
| Q35801008 | A-Subclass ATP-Binding Cassette Proteins in Brain Lipid Homeostasis and Neurodegeneration |
| Q38789606 | ATP increases the migration of microglia across the brain endothelial cell monolayer |
| Q54181615 | Acute induction of adriamycin-resistance in human colon carcinoma HT-29 cells exposed to a sublethal dose of adriamycin. |
| Q40068292 | Adverse effect of cyclosporin A on barrier functions of cerebral microvascular endothelial cells after hypoxia-reoxygenation damage in vitro |
| Q48264476 | An inhibitory role of nitric oxide in the dynamic regulation of the blood-brain barrier function |
| Q40534105 | Antibodies in the study of multiple drug resistance |
| Q36595837 | Apicobasal polarity of brain endothelial cells |
| Q24798696 | Astroglial expression of the P-glycoprotein is controlled by intracellular CNTF. |
| Q34067977 | BBB transport and P-glycoprotein functionality using MDR1A (-/-) and wild-type mice. Total brain versus microdialysis concentration profiles of rhodamine-123. |
| Q36688328 | Barrier properties of testis microvessels |
| Q33851297 | Brain microvascular P-glycoprotein and a revised model of multidrug resistance in brain |
| Q42319809 | CAN a P-gp modulator assist in the control of methotrexate concentrations in the rat brain? -inhibitory effects of rhodamine 123, a specific substrate for P-gp, on methotrexate excretion from the rat brain and its optimal route of administration |
| Q30584978 | Characterisation of the clinical pharmacokinetics of actinomycin D and the influence of ABCB1 pharmacogenetic variation on actinomycin D disposition in children with cancer |
| Q37447674 | Characterization of the endocannabinoid system in human neuronal cells and proteomic analysis of anandamide-induced apoptosis |
| Q42609401 | Chelating compound, chrysoidine, is more effective in both antiprion activity and brain endothelial permeability than quinacrine |
| Q40764143 | Conditionally immortalized brain capillary endothelial cell lines established from a transgenic mouse harboring temperature-sensitive simian virus 40 large T-antigen gene |
| Q33851314 | Determinants of passive drug entry into the central nervous system |
| Q74549985 | Effect of GF120918, a potent P-glycoprotein inhibitor, on morphine pharmacokinetics and pharmacodynamics in the rat |
| Q44742564 | Effect of P-glycoprotein inhibitors erythromycin and cyclosporin A on brain pharmacokinetics of nimodipine in rats |
| Q28363738 | Effect of P-glycoprotein modulators on the pharmacokinetics of camptothecin using microdialysis |
| Q38695766 | Effect of shear stress on iPSC-derived human brain microvascular endothelial cells (dhBMECs). |
| Q57810063 | Elimination of substances from the brain parenchyma: efflux via perivascular pathways and via the blood-brain barrier |
| Q80990606 | Endothelin-1 reduces p-glycoprotein transport activity in an in vitro model of human adult blood-brain barrier |
| Q48527215 | Evaluation of the role of P-glycoprotein in ivermectin uptake by primary cultures of bovine brain microvessel endothelial cells |
| Q34402344 | Evidence for P-glycoprotein-modulated penetration of morphine-6-glucuronide into brain capillary endothelium |
| Q71017964 | Functional expression of the P-glycoprotein mdr in primary cultures of bovine cerebral capillary endothelial cells |
| Q88648647 | Imatinib-induced ophthalmological side-effects in GIST patients are associated with the variations of EGFR, SLC22A1, SLC22A5 and ABCB1 |
| Q38414396 | Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature |
| Q40552620 | Impacts of blood-brain barrier in drug delivery and targeting of brain tumors |
| Q33248008 | In situ localization of P-glycoprotein (ABCB1) in human and rat brain |
| Q33976215 | In vivo and in vitro toxicodynamic analyses of new quinolone-and nonsteroidal anti-inflammatory drug-induced effects on the central nervous system |
| Q47752176 | Inhibition of P-glycoprotein: rapid assessment of its implication in blood-brain barrier integrity and drug transport to the brain by an in vitro model of the blood-brain barrier. |
| Q48326027 | Inhibition of transforming growth factor-beta production in brain pericytes contributes to cyclosporin A-induced dysfunction of the blood-brain barrier |
| Q35330589 | Interleukin-1β induces blood-brain barrier disruption by downregulating Sonic hedgehog in astrocytes |
| Q33553749 | Interleukin-25 expressed by brain capillary endothelial cells maintains blood-brain barrier function in a protein kinase Cepsilon-dependent manner |
| Q35533000 | Interleukin-34 restores blood-brain barrier integrity by upregulating tight junction proteins in endothelial cells. |
| Q40839362 | Involvement of glial cells in cyclosporine-increased permeability of brain endothelial cells |
| Q40042601 | Involvement of the lysophosphatidic acid-generating enzyme autotaxin in lymphocyte-endothelial cell interactions |
| Q52728665 | Ionophore and Biometal Modulation of P-glycoprotein Expression and Function in Human Brain Microvascular Endothelial Cells. |
| Q42822886 | Isoform I (mdr3) is the major form of P-glycoprotein expressed in mouse brain capillaries. Evidence for cross-reactivity of antibody C219 with an unrelated protein |
| Q35782089 | MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors. |
| Q40535310 | Molecular analysis of the multidrug transporter |
| Q37349714 | Mrp4 confers resistance to topotecan and protects the brain from chemotherapy |
| Q41052675 | Multidrug resistance in cancer chemotherapy |
| Q36430974 | Murine P-glycoprotein on stromal vessels mediates multidrug resistance in intracerebral human glioma xenografts |
| Q37988811 | Neurovascular unit: a focus on pericytes |
| Q34349313 | Overcoming drug resistance by regulating nuclear receptors |
| Q41827476 | Overexpression of lncRNA NEAT1 mitigates multidrug resistance by inhibiting ABCG2 in leukemia |
| Q36166111 | Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology. |
| Q36136731 | Positron emission tomography studies on binding of central nervous system drugs and P-glycoprotein function in the rodent brain. |
| Q40639360 | Prediction of drug transport through the blood-brain barrier in vivo: a comparison between two in vitro cell models. |
| Q37391961 | Prodrugs of thyrotropin-releasing hormone and related peptides as central nervous system agents |
| Q41789594 | Rap1 translates chemokine signals to integrin activation, cell polarization, and motility across vascular endothelium under flow |
| Q35029495 | Role of P-glycoprotein in pharmacokinetics: clinical implications |
| Q36970368 | Synthesis and Preclinical Evaluation of Sulfonamido-based [(11)C-Carbonyl]-Carbamates and Ureas for Imaging Monoacylglycerol Lipase |
| Q36926261 | Synthesis and Preliminary PET Imaging Studies of a FAAH Radiotracer ([¹¹C]MPPO) Based on α-Ketoheterocyclic Scaffold. |
| Q46771818 | Synthesis and Preliminary Studies of a Novel Negative Allosteric Modulator, 7-((2,5-Dioxopyrrolidin-1-yl)methyl)-4-(2-fluoro-4-[11C]methoxyphenyl) quinoline-2-carboxamide, for Imaging of Metabotropic Glutamate Receptor 2. |
| Q62039080 | Synthesis, pharmacology and preclinical evaluation of C-labeled 1,3-dihydro-2H-benzo[d]imidazole-2-ones for imaging γ8-dependent transmembrane AMPA receptor regulatory protein |
| Q40514016 | The biology of the P-glycoproteins |
| Q34558556 | The impact of efflux transporters in the brain on the development of drugs for CNS disorders |
| Q41823871 | The role of P-glycoprotein in blood-brain barrier transport of morphine: transcortical microdialysis studies in mdr1a (-/-) and mdr1a (+/+) mice. |
| Q37117550 | The role of multidrug resistance-associated protein in the blood-brain barrier and opioid analgesia |
| Q36021057 | Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporter |
| Q38265501 | Transferrin Receptor 1 Facilitates Poliovirus Permeation of Mouse Brain Capillary Endothelial Cells |
| Q40543578 | Transforming growth factor-beta1 upregulates the tight junction and P-glycoprotein of brain microvascular endothelial cells |
| Q34059731 | Ultrastructural localization of P-glycoprotein on capillary endothelial cells in human gliomas |
| Q40549490 | Uptake and efflux of quinacrine, a candidate for the treatment of prion diseases, at the blood-brain barrier |